1 – 10 of 274
- show: 10
- |
- sort: year (new to old)
- |
- Export
- 2023
- The short-term false positives after sacral neuromodulation therapy : who, how many and why? A prospective descriptive single centre study (2023) CONTINENCE (AMSTERDAM). 6.
- The low dopamine hypothesis : a plausible mechanism underpinning residual urine, overactive bladder and nocturia (RON) syndrome in older patients (2023) PROGRES EN UROLOGIE. 33(4). p.155-171
- Nocturomics : transition to omics‐driven biomarkers, a systematic review and future prospects (2023) BJU INTERNATIONAL.
- 2022
- Enhancing safety of desmopressin in elderly : validation of capillary blood sodium levels (2022) CONTINENCE (AMSTERDAM). In Continence 2(supplement 2).
- Nocturia severely impairs the sleep quality of nursing home residents : results from a multi-center study (2022) GERIATRIC NURSING. 48. p.160-164
- De novo nocturia : a red flag for coronary heart disease patients (2022) PROGRES EN UROLOGIE. 32(11). p.756-762
- Prevalence of short-term false positives after sacral neuromodulation therapy and the potential role of a place effect : a prospective descriptive single centre study (2022) CONTINENCE (AMSTERDAM). In Continence (Amsterdam) 2(supplement 2).
- Nachtelijke polyurie bij patiënten met een ruggenmergletsel (2022)
- Salt and urea as driving force of diuresis : potential dietary impact for therapy and prevention of nocturia (2022)
- Laying the foundation for enhancing safety of desmopressin in older people : validation of capillary blood sodium levels (2022) NEUROUROLOGY AND URODYNAMICS.